Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

NCT04883827 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT04883827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04883827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Observational
Overall status
Completed
Start date
January 6, 2021
Completion date
December 1, 2023
Enrollment
180 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma